Name of Study
COS-DAP: Developing a core outcome set for diabetes after pregnancy prevention
Purpose of Study
Diabetes After Pregnancy (DAP) often occurs in the years that follow a pregnancy complicated by Gestational Diabetes Mellitus (GDM). Many research groups are working to develop and test DAP prevention strategies. These large and long studies require lots of funding to study the relationship between prevention strategies and DAP occurring. Smaller, shorter studies tend to use outcomes other than DAP occurring to figure out if they are effective and different studies often measure different outcomes, making it difficult to compare results. Core Outcome Set (COS) projects work to create a list of essential outcomes that need to be measured in studies to ensure the results can be used effectively.
The COS-DAP project will identify a COS for future DAP prevention studies.
If you are a healthcare professional and/or researcher, you are an expert in the management of gestational diabetes, its associated risks, and the types of interventions that may prevent diabetes after pregnancy. If you are a woman with previous gestational diabetes, you are an expert in living with and managing this condition. We are looking for experts to participate in the COS-DAP survey.
Type of Study (observational/exploratory etc)
Survey
Are you recruiting participants for this trail?
Yes
Geographical location of study
Online – anywhere
Who can take part?
Adults over 18 years old – women with gestational diabetes, healthcare professionals and researchers
What will the participants be asked to do?
We have put together a list of possible outcome measures based on a systematic review of previous studies.
We need your help through a two-round online Delphi survey to figure out which ones are the ‘core outcomes.’
The rounds are approximately one month apart.
Each takes an estimated 10-15 minutes and may be completed in one or multiple sittings, as you prefer.
Recruitment Start Date
23/07/2018
Recruitment Finish Date
25/08/2018
Study Duration
3 weeks
This study is funded by:
Canadian Institute of Health Research
For further information contact:
Dr Sharleen O’Reilly
Phone
01 7162157